Quetiapine modulates functional connectivity in brain aggression networks.

Area of Science:

• Neuroscience
• Psychopharmacology
• Neuroimaging

Background:

• Aggressive behavior is linked to dysfunctions in the amygdala and prefrontal cortex (PFC) affective regulation network.
• Prefrontal regions are thought to inhibit amygdala activity, a process potentially impaired in aggressive individuals.
• The atypical antipsychotic quetiapine reduces aggression, but its neural mechanisms remain unclear.

Purpose of the Study:

• To investigate the in-vivo effects of quetiapine on corticolimbic functional connectivity during virtual aggressive behavior.
• To explore the neurobiological underpinnings of quetiapine's anti-aggressive effects.

Main Methods:

• A double-blind, placebo-controlled study using fMRI to assess functional brain connectivity.
• Participants underwent three days of quetiapine or placebo administration prior to the fMRI experiment.
• Functional connectivity was measured during a virtual aggression task (violent video game) and a non-violent control task.

Main Results:

• Quetiapine significantly increased functional connectivity between the ACC and DLPFC with the amygdala during virtual aggression.
• Conversely, quetiapine attenuated orbitofrontal cortex (OFC)-amygdala coupling during the aggression task.
• These quetiapine-induced changes in connectivity were specific to the aggression task and not observed with placebo or the control task.

Conclusions:

• Quetiapine pharmacologically modulates aggression-related human brain networks, specifically the prefrontal-amygdala system.
• The findings provide a neurobiological model for quetiapine's anti-aggressive effects, highlighting violence-specific network modulation.
• This study offers the first in-vivo evidence of pharmacological influence on corticolimbic pathways during human aggression.